1-Butyl-3-methylimidazolium tosylate

Catalog No. :
ACDBQK827
CAS No. :
410522-18-8
Molecular Formula :
C15H22N2O3S
Molecular Weight :
310.42

IUPAC Name:1-butyl-3-methyl-1H-imidazol-3-ium 4-methylbenzenesulfonate

1-Butyl-3-methylimidazolium tosylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g99%$60.00Login to see priceIn stockInquiry
100g99%$180.00Login to see priceIn stockInquiry
500g99%$744.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Butyl-3-methylimidazolium tosylate
IUPAC Name1-butyl-3-methyl-1H-imidazol-3-ium 4-methylbenzenesulfonate
MDL No.MFCD04973308
Molecular FormulaC15H22N2O3S
Molecular Weight310.42
SMILESC[N+]1=CN(CCCC)C=C1.[O-]S(=O)(C2=CC=C(C)C=C2)=O
InChI KeyVWFZFKKEKWMXIA-UHFFFAOYSA-M
Synonym1-butyl-3-methylimidazolium p-toluenesulfonate | DTXSID90467401 | CS-W012064 | 1-butyl-3-methylimidazol-3-ium;4-methylbenzenesulfonate | A873161 | MFCD04973308 | Q-102705 | 3-Butyl-1-methyl-3-imidazolium 4-Methylbenzenesulfonate | VWFZFKKEKWMXIA-UHFFFAOYS
CAS No.410522-18-8
PubChem CID11483731

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDBQK827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDBQK827 route product structure diagram
    ACDBQK827410522-18-8 In Stock
Inquiry

2. ACDBQK827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDBQK827 route product structure diagram
    ACDBQK827410522-18-8 In Stock
Inquiry

Comments (0)